Monday Jul 7
Immuron FY2014 Travelan Sales Exceed $1 Million
These revenues are approximately seven times the company's FY2013 Travelan revenues of approximately $150K.
Eli Lilly and major shareholder Lilly Endowment Inc Unloads 245,000 Shares
Eli Lilly and major shareholder Lilly Endowment Inc sold 245,000 shares of the stock in a transaction dated Wednesday, June 25th.
Eli Lilly and major shareholder Sells $14,156,500 in Stock
Eli Lilly and major shareholder Lilly Endowment Inc sold 230,000 shares of the company's stock on the open market in a transaction dated Friday, June 20th.
Eli Lilly drug comes up short in liver cancer trial
A study on patients with advanced liver cancer using Eli Lilly and Co.' s new cancer drug Cyramza failed to meet its primary goal of overall patient survival.
Eli Lilly and Given Consensus Recommendation of "Hold" by Brokerages
Eli Lilly and has received an average rating of "Hold" from the nineteen brokerages that are presently covering the stock, ARN reports .